MYEC Opinions 08/18/2014 17:18:56 $MYEC If you are

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
MYEC Opinions 08/18/2014 17:18:56 $MYEC
If you are patient, you'll make money here, IMO
Up 41% today, awesome. Only another 70% to go to be even.
Unless theres another nice candle tomorrow or at least consolidation its for not i got a feel ed isnt stupid enough to throw out one PR and not have any till say october he needs to re esstablish shareholder sentiment. Looking for more this week in terms of news with ed at the trade expo
Extremism abound...the stock goes down and folks are in stock shock and now it's up just a tad still in horrible price range for late comers and folks are taking champainge baths...It's still miles to go before being a respectable recovery...At least let's see a few more white candles and a close above the 100 DMA...

T
MYEC. 8 Reasons to Buy MYEC

1)MYEC is, in almost every single capacity, a stand out company for the OTC market. It has positive fundamentals, patents, earnings, a mobile app, and intangibly but perhaps most importantly, potential for future growth.

2)MYEC is way above par and way under the radar.

3)Annual trends for MYEC are broadly and overwhelmingly positive harbingers for steady company growth

4) In Q2 2014 MyECheck entered into MyECheck Services Agreements with two important accounts, iCard1 and VX Gateway, both of these partners bring to the Company strategic value in addition to revenue.

5)The new patented payment method is the fastest, most secure and most cost effective method of processing payments in the US, and it works with the most people, businesses and entities.

6)MYEC is doing what they need to be doing at the current time to keep growing. They are posting good earnings through legitimate audited financials, they are releasing PRs when relevant and avoiding fluff news, they are acquiring new brands, and larger clients, they are hiring employees, they are working off of the patents that they have to make a play into the medical marijuana industry.

7) MYEC will easily become a multibillion dollar company. I think that an OTC investor needs to realize that MyECheck is fighting some huge names including PayPal, Venmo, Alipay (which will become more of a global factor once Alibaba (Pending:BABA) goes public), and more.

8)MYEC is to be bought out by one of the industry giants.

GLTA Longs !!!
MYEC. Post by T10. MYEC.
you don't think its going back to 3-4 cents...that's too bad
Very true
Correct, as we sign more clients revs and stock price will follow.

Our patent separates us from other check processing company. They will have to license with us for Check 21.

We really have something special here, just needs to play out.

IMO.
I hate to get keep bringing it up but when you say apps July 1, mjpay and then nothing...that does have something to do with the sp dropping but I get what you are saying.
I'm curious to see if we were able to get Ed on the list for Payment Visionaries

http://paybefore.com/free-content/make-your-p...sionaries/

Doesn't look like the Fall edition comes out til Oct tho
The pps isn't in direct control by Myecheck. But their business is, and that's what we should be measuring by.
Agreed. Once things start happening and revenue start rolling in the sp will rise.
Disagree there.
Here you go...

https://www.youtube.com/watch?v=Auxn2VAdiKI

Yes, we are on the path to prosperity.

Go $MYEC
A long way to go before any repectability will return...at least over 3-4 cents..
Nice day. We still have lots of work. Good job MYEC. Looking forward to more client signings and uplisting.


Toldya, toldya, toldya so! No (more)subpennies for MYEC! ;&
Waiting for Ed and Nate's picture to be posted...

https://www.facebook.com/pages/The-Prepaid-Pr...1721979791
So subs tmrw ? ................lolzzzzzzzzzzzzzz
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

TuHURA Biosciences Advances Phase 3 Trial for Cancer Treatment

Updated Category News Views 229

TuHURA Biosciences Moves Forward with Phase 3 Trial TuHURA Biosciences, Inc. (NASDAQ: HURA) is making substantial strides in the field of cancer immunotherapy. The company is geared up to launch its Phase 3 accelerated approval trial of IFx-2.0, a promising adjunctive therapy in combination with Keytruda (pembrolizumab), targeting advanced and metastatic Merkel cell...

Continue Reading
Fiserv, Inc. Lawsuit: Investors Can Fight Back Against Losses

Updated Category News Views 198

Introduction to the Class Action Lawsuit In recent news, numerous investors in Fiserv, Inc. are being alerted to an important opportunity. A class action lawsuit has been initiated targeting Fiserv, a prominent figure in the financial services tech sector. This situation arises from allegations of significant financial losses endured by shareholders due to the Company's...

Continue Reading
Exploring Humana's Decreased Short Interest and Market Impact

Updated Category News Views 104

Understanding Humana's Short Interest Trends Recently, Humana Inc (NYSE: HUM) has reported a notable decline in its short percent of float, decreasing by 6.3% since the previous report. As of now, the company has approximately 4.30 million shares sold short, which constitutes about 3.57% of the total shares available for trading. Based on the current trading volumes, it...

Continue Reading
Innovative Restaurant Launch Featuring AI Robots Opens Soon

Updated Category News Views 344

AI-Driven Restaurant Opening at Walmart Supercenter In an exciting development for the dining industry, Richtech Robotics Inc. (NASDAQ: RR), a leader in AI-driven service robots, has joined forces with Ghost Kitchens America to unveil their latest One Kitchen restaurant. This location, situated within a Walmart Supercenter, is marking a significant milestone as it becomes...

Continue Reading
Choosing the Perfect MySmile Teeth Whitening Solution for You

Updated Category News Views 82

Your Guide to MySmile Teeth Whitening Products Achieving a whiter, brighter smile is easier than ever with MySmile's effective teeth whitening solutions. MySmile offers a range of products tailored to fit different lifestyles; whether you're interested in an all-in-one kit, convenient whitening strips, or one-step solutions, the right product is just a choice away. Let's...

Continue Reading